Norwich Research Park has reached a significant milestone, with its member companies collectively surpassing £200 million in funding. This achievement underscores the vibrant ecosystem of approximately 50 companies located within the park, ranging from emerging start-ups to established international enterprises employing over 100 individuals.
The businesses that successfully attract investment are typically those that have demonstrated proof of concept for their innovative ideas, facilitating the commercialisation and scaling of their propositions.
Highlighting Successful Companies
Among the notable companies at Norwich Research Park is Tropic, which has evolved from three employees to a workforce of around 150 over the past decade. In the last five years, Tropic has raised an impressive total of $190 million (£142 million), with $105 million (£79 million) secured earlier this month to support its research and development activities. Last year, Tropic launched its first commercial product—a gene-edited non-browning banana—which received recognition from TIME magazine as one of the best inventions of 2025.
Another innovative company, Resurrect Bio, a biotech firm focused on enhancing crops with genetic resistance to diseases, has recently completed the initial closing of its Series A funding round, securing $8.1 million (£6.1 million). This funding will aid in the advancement of its high-throughput trait discovery platform and support the development of various disease-resistance products for future commercial partnerships.
Having relocated from Canada to Norwich Research Park in February 2024 following a successful seed raise of $4.4 million (£3.3 million), the founders of Resurrect Bio aim to develop gene-edited rice varieties that exhibit increased heat tolerance and higher yields in response to climate change challenges.
Alora has also recently garnered investment from the Neglected Climate Opportunities Fund—a climate-focused venture capital entity under the Grantham Environment Trust—alongside participation from Toyota Ventures. Rory Hornby, COO and co-founder of Alora, remarked on the benefits of relocating to Norwich, noting the significant acceleration in the company’s progress since joining the park.
QuberTech, another prominent player, is spearheading a precision breeding initiative known as QuBOOSTR, in collaboration with the John Innes Centre and LettUs Grow. Supported by £2.4 million from the UK Government’s Defra Farming Innovation Programme in partnership with Innovate UK, this project aims to explore the potential of extracting latex from dandelion roots as a sustainable source of natural rubber.
Ikarovec has made strides in addressing intermediate age-related macular degeneration (AMD), a condition that can lead to severe vision impairment if untreated. The company has successfully raised approximately £8 million and has recently entered into a global agreement with VectorBuilder, a leader in gene delivery technology. With no approved drug treatments currently available in this untapped market, Ikarovec’s solution has the potential to access a market valued at over $1 billion in the coming years.
TraitSeq has also made notable progress by partnering with Syngenta, a leading entity in developing next-generation biological products for agriculture. Syngenta will utilise TraitSeq’s platform to analyse complex biological data, thereby uncovering the intricate molecular interactions that influence a crop’s ability to utilise nutrients from the soil.
Support for New Ventures
The Anglia Innovation Partnership, the management organisation of Norwich Research Park, is committed to maintaining this momentum. An incubation programme has been established to nurture new enterprises founded by researchers, scientists, and entrepreneurs.
In 2025, the partnership provided tailored support to 17 new companies, focusing on areas such as funding, intellectual property protection, patents, and marketing. Since 2022, £650,000 has been allocated in pre-seed funding to assist start-ups in establishing proof of concepts for their ideas.
Furthermore, Anglia Innovation Partnership is extending business support to an additional 40 early-stage companies as part of its Campus Enterprise Strategy.
Roz Bird, CEO of Anglia Innovation Partnership, expressed her enthusiasm regarding the achievements at Norwich Research Park, noting the excellent facilities and specialised skills available that contribute to its reputation as a prime location for high-growth companies in agri-food, health, nutrition, and environmental sectors. The surpassing of the £200 million funding milestone is a remarkable accomplishment, encouraging continued efforts to position Norwich Research Park as one of the leading locations for establishing and growing companies in global markets.
For more information, visit norwichresearchpark.com.